As a Senior Business Executive, I oversee all operational functions across diverse publicly traded companies. Leading business development and M&A efforts, I implement proactive and forward-thinking tactics that identify and capitalize on strategic partnerships, alliances, and acquisition opportunities to position companies as key players in highly regulated industries.Specializing in biotech and life sciences, I led an operations team in 2021 to receive a Biologics License Application (BLA) from the US FDA for a ground-breaking plasma-derived therapeutic drug targeting an orphan disease. Following the successful BLA, I negotiated the sale of the FDA priority review voucher.As a strategic business partner, I safeguard and monetize intellectual property, facilitating transactions such as licensing and collaboration agreements globally across Asia, Russia, USA, and Europe.My hands-on approach to restructuring involves securing 30+ financing efforts through debt financing, equity raises, and asset monetization, while overseeing the sale of businesses to enable the long-term financial security of an organization. Dedicated to fostering a culture of innovation and collaboration, I guide teams towards shared success through a commitment to excellence.Fluent in English, French, and ItalianHonoured as Concordia University’s Top 50 under 50 in 2023.